FDA Issues New Guidance On Dose Optimization For Oncology Therapies
In January 2023, the FDA issued a new draft guidance document on optimizing the dosage of drugs and biological products for the treatment of...
United States Marjoriee Zettler Karyopharm Therapeutics Inc Oncology Center Drug Administration Regor Pharmaceuticals Inc
Source: clinicalleader.com